Nov 11, 2021 / 04:20PM GMT
Jailendra P. Singh - Crédit Suisse AG - Research Division - Research Analyst
All right. Good morning, everyone. I'm Jailendra Singh, health care technology and distribution analyst at Crédit Suisse. Thanks, everyone, for joining us for this session. Next up, we have OptimizeRx. From the company, we have Will Febbo, CEO and Director; Ed Stelmakh, CFO; and Andy D'Silva, SVP of Finance.
OptimizeRx is a health technology company enabling care-focused engagement between life sciences automization, health care providers and patients at critical junctures throughout the patient journey. I have some prepared questions, so we are doing this in a fireside chat format. I'll plan to cover that. But if anyone from the audience has a question, please e-mail them to me at [email protected].
Will, Ed, Andy, thank you so much for doing this. Really appreciate it.
William J. Febbo - OptimizeRx Corporation - CEO & Director
Nice to be here.
Edward Stelmakh - OptimizeRx Corporation - CFO
OPTIMIZERx Corp at Credit Suisse Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot